1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, October 2016 (p7)

Biological Therapy Analysis & Statistics, October 2016 (p7)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

181-210 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

Theravectys SA - Product Pipeline Review - 2016

Theravectys SA - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • October 2016
  • by Global Markets Direct

Theravectys SA - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Theravectys SA - Product Pipeline Review - 2016’, provides an overview of the Theravectys SA’s pharmaceutical research ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology, Therapy, Research and Development, Cancer
  • Countries : World
Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company provides elelyso, a plant cell-expressed ...

  • Industries : Biological Therapy
International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the ...

  • Industries : Biological Therapy
Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review

Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Japan Tissue Engineering Co., Ltd. (J-TEC) is a bio-venture company that develops, manufactures and sells tissue-engineered medical products and related products. The company's products include ...

  • Countries : Japan
Genome Editing/Genome Engineering Market by Technology, Applications, End User - Global Forecast to 2021

Genome Editing/Genome Engineering Market by Technology, Applications, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing ...

  • Industries : Biotechnology, Genomics
  • Countries : World
Global CRISPR/Cas9 Market Outlook 2022

Global CRISPR/Cas9 Market Outlook 2022

  • $ 1200
  • Industry report
  • October 2016
  • by RNCOS

The advent of CRISPR/Cas9 has revolutionized the Genome Editing Industry. This technique is allowing a previously unattainable level of genomic targeting with greater efficiency and simplicity. Due to ...

  • Industries : Biological Therapy
  • Countries : World, North America
Human Stem Cells Institute (ISKJ) - Financial and Strategic SWOT Analysis Review

Human Stem Cells Institute (ISKJ) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Human Stem Cells Institute (HSCI) is a biotechnology company that carries out the discovery, research and development, and marketing of proprietary products and services in the areas of regenerative ...

  • Industries : Biological Therapy
Pathfinder Cell Therapy Inc (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy Inc (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Pathfinder Cell Therapy Inc (Pathfinder) is a regenerative medicine company that develops novel based therapies. The company has discovered a new mammalian cell type which is able to stimulate ...

  • Industries : Biological Therapy
Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)

Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • October 2016
  • by Industry ARC

RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and ...

  • Industries : Biological Therapy
  • Countries : Asia
Therapeutic Vaccine Market: By Vaccine Type (Addiction, Neurological, Infectious, Autoimmune); By Technology (Autologous, Allogenic) & By Region -Forecast (2016-2021)

Therapeutic Vaccine Market: By Vaccine Type (Addiction, Neurological, Infectious, Autoimmune); By Technology (Autologous, Allogenic) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • October 2016
  • by Industry ARC

A vaccine is a biological medical product designed to stimulate antibodies inside the human body against any antibody attack. Vaccine helps in providing immunity against various infectious diseases. Vaccines ...

  • Industries : Therapy, Biopharmaceutical
Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016–2021). In this report, ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, Europe, North America
Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • $ 1350
  • Industry report
  • October 2016
  • by Igate Research

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The ...

  • Industries : Biopharmaceutical, Generic Drug, Biotechnology, Pharmaceutical
  • Countries : World
Cell Expansion Global Market - Forecast to 2022

Cell Expansion Global Market - Forecast to 2022

  • $ 4950
  • Industry report
  • October 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Cell expansion technology has been emerging as a promising therapeutic solution for many diseases and is used for engineering, replacing, or regenerating human tissues, cells, and organs to restore normal ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
Biopreservation - Global Market Outlook (2016-2022)

Biopreservation - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biopreservation Market is accounted for $2.17 billion in 2015 and is expected to reach $4.75 billion by 2022 growing at a CAGR of 11.84% during the forecast period. ...

  • Industries : Biological Therapy
  • Countries : World, Asia, North America, Europe
3D Cell Culture - Global Market Outlook (2016-2022)

3D Cell Culture - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global 3D Cell Culture Market is accounted for $375.25 million in 2015 and is expected to reach $1520.15 million by 2022 growing at a CAGR of 22.1% during the forecast ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World
Stem Cell Banking - Global Market Outlook (2016-2022)

Stem Cell Banking - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. ...

  • Industries : Banking
  • Countries : World
Single-Cell Analysis - Global Market Outlook (2016-2022)

Single-Cell Analysis - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Single-Cell Analysis market is estimated at $1.22 billion in 2015 and is expected to reach $4.25 billion by 2022 growing at a CAGR of 19.5% from 2015 to 2022. Growing ...

  • Industries : Biological Therapy
  • Countries : World, Asia, Europe, North America
Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025

Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025

  • $ 4200
  • Industry report
  • October 2016
  • by Accuray Research LLP

The Global Allergy Immunotherapy Market is poised to grow at a CAGR of around 8.2% from 2015 to 2025. Some of the prominent trends that the market is witnessing include unmet need for healthcare in developing ...

  • Industries : Biological Therapy
  • Countries : United States
Global Animal Health Partnering Terms and Agreements 2010 to 2016

Global Animal Health Partnering Terms and Agreements 2010 to 2016

  • $ 1995
  • Industry report
  • October 2016
  • by Currentpartnering

Welcome to the Global Animal Health Partnering Terms and Agreements 2010 to 2016 report. The report provides a detailed understanding and analysis of how and why companies enter Animal Health partnering ...

  • Industries : Veterinary Healthcare, Healthcare, Pathology, Biotechnology, Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

  • Industries : Biological Therapy, Pathology, Healthcare, Biotechnology, Therapy
  • Countries : United States
Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Gene therapy has emerged as a promising treatment option for various diseases (primarily the ones that currently have no cure) including cancers, inherited disorders and some viral infections. ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

  • $ 220
  • Industry report
  • October 2016
  • by La Merie Publishing

CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains information about TCR & CAR engineered T-cells and NK cells ...

  • Industries : Biological Therapy
Hepatitis C - Pipeline Review, H2 2016

Hepatitis C - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Hepatitis C - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology, Healthcare
  • Countries : United States
MediGene AG - Product Pipeline Review - 2016

MediGene AG - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • September 2016
  • by Global Markets Direct

MediGene AG - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘MediGene AG - Product Pipeline Review - 2016’, provides an overview of the MediGene AG’s pharmaceutical research and ...

  • Industries : Biological Therapy, Biotechnology, Therapy, Cancer
  • Countries : World, United States
Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2016

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leber Congenital Amaurosis (LCA) - Pipeline Review, ...

  • Industries : Therapy
  • Countries : United States
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016’, ...

  • Industries : Biological Therapy, Cancer, Therapy, Pathology, Pharmaceutical
  • Countries : Japan, United States, World
ChemoCentryx, Inc. - Product Pipeline Review - 2016

ChemoCentryx, Inc. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • September 2016
  • by Global Markets Direct

ChemoCentryx, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘ChemoCentryx, Inc. - Product Pipeline Review - 2016’, provides an overview of the ChemoCentryx, Inc.’s pharmaceutical ...

  • Industries : Pathology, Therapy, Biological Therapy
  • Countries : World, United States
C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2016

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine ...

  • Industries : Therapy, Biological Therapy
  • Countries : United States, World
Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2016

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
About 3600 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in the US

  • January 2017
    7 pages
  • Biological Ther...  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.